the earlier onset of rapid bactericidal action and the prolonged postantibiotic effect of ciprofloxacin ( demonstrated in vivo and in vitro ) were , in all likelihood , the factors that allowed the successful use of fewer doses of this antimicrobial agent at relatively longer dosing intervals .
C0008809
ciprofloxacin
C1136254
antimicrobial agent